ValuEngine lowered shares of Tenet Healthcare (NYSE:THC) from a hold rating to a sell rating in a report published on Wednesday.
Other equities research analysts have also issued reports about the company. Robert W. Baird restated a buy rating and set a $35.00 price target on shares of Tenet Healthcare in a research report on Wednesday, November 7th. Zacks Investment Research raised Tenet Healthcare from a hold rating to a buy rating and set a $36.00 price objective on the stock in a report on Wednesday, August 8th. Mizuho set a $36.00 price objective on Tenet Healthcare and gave the stock a buy rating in a report on Tuesday, August 7th. Barclays began coverage on Tenet Healthcare in a report on Tuesday, August 14th. They set an equal weight rating and a $35.00 price objective on the stock. Finally, Piper Jaffray Companies reaffirmed a hold rating and set a $34.00 price objective on shares of Tenet Healthcare in a report on Wednesday, August 8th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the company. Tenet Healthcare presently has a consensus rating of Hold and a consensus target price of $31.13.
NYSE THC opened at $22.47 on Wednesday. The company has a market cap of $2.31 billion, a P/E ratio of 27.74, a price-to-earnings-growth ratio of 1.12 and a beta of 0.87. Tenet Healthcare has a one year low of $12.45 and a one year high of $39.74. The company has a debt-to-equity ratio of 21.55, a quick ratio of 0.99 and a current ratio of 1.06.
A number of large investors have recently bought and sold shares of THC. Vanguard Group Inc. lifted its holdings in Tenet Healthcare by 9.4% during the 3rd quarter. Vanguard Group Inc. now owns 11,496,136 shares of the company’s stock worth $327,180,000 after buying an additional 990,373 shares in the last quarter. Partner Fund Management L.P. lifted its stake in shares of Tenet Healthcare by 22.2% in the 2nd quarter. Partner Fund Management L.P. now owns 4,336,946 shares of the company’s stock valued at $145,591,000 after purchasing an additional 786,785 shares during the period. Morgan Stanley lifted its stake in shares of Tenet Healthcare by 165.3% in the 2nd quarter. Morgan Stanley now owns 1,167,972 shares of the company’s stock valued at $39,208,000 after purchasing an additional 727,713 shares during the period. Point72 Asset Management L.P. acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at $16,949,000. Finally, Hood River Capital Management LLC acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at $15,094,000.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Story: What is the Rule of 72?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.